Global Oral Vaccines Market Size, Manufacturers, Opportunities and Forecast to 2030
Summary
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.
According to APO Research, The global Oral Vaccines market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.
North American market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Oral Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Oral Vaccines include Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol and PaxVax, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Oral Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Vaccines.
The Oral Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oral Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Merck
- GSK
- Sanofi
- Lanzhou Institute
- Serum Institute
- Valneva
- Shanghai United Cell
- Bibcol
- PaxVax
- Vabiotech
- Tiantan Biological
- EuBiologics
- Panacea Biotec Ltd
- Bio-Med
- Halfkin Bio-Pharmaceuticals
- Rotavirus Vaccine
- Cholera Vaccine
- Oral Polio Vaccine
- Public
- Private
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oral Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oral Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Oral Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Oral Vaccines Market by Type
1.3.1 Rotavirus Vaccine
1.3.2 Cholera Vaccine
1.3.3 Oral Polio Vaccine
1.4 Global Oral Vaccines Market Size by Type
1.4.1 Global Oral Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Oral Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Oral Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Oral Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Oral Vaccines Revenue (2019-2024)
3.2 Global Top Players by Oral Vaccines Sales (2019-2024)
3.3 Global Top Players by Oral Vaccines Price (2019-2024)
3.4 Global Oral Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Oral Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Oral Vaccines Company, Product Type & Application
3.7 Global Oral Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
4 ORAL VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Oral Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Oral Vaccines Historic Market Size by Region
4.2.1 Global Oral Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Oral Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Oral Vaccines Forecasted Market Size by Region
4.3.1 Global Oral Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Oral Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ORAL VACCINES BY APPLICATION
5.1 Oral Vaccines Market by Application
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Market Size by Application
5.2.1 Global Oral Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Oral Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Oral Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Oral Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments
6.3 Sanofi
6.3.1 Sanofi Comapny Information
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Comapny Information
6.4.2 Lanzhou Institute Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments
6.5 Serum Institute
6.5.1 Serum Institute Comapny Information
6.5.2 Serum Institute Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments
6.6 Valneva
6.6.1 Valneva Comapny Information
6.6.2 Valneva Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments
6.7 Shanghai United Cell
6.7.1 Shanghai United Cell Comapny Information
6.7.2 Shanghai United Cell Business Overview
6.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments
6.8 Bibcol
6.8.1 Bibcol Comapny Information
6.8.2 Bibcol Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments
6.9 PaxVax
6.9.1 PaxVax Comapny Information
6.9.2 PaxVax Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments
6.10 Vabiotech
6.10.1 Vabiotech Comapny Information
6.10.2 Vabiotech Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments
6.11 Tiantan Biological
6.11.1 Tiantan Biological Comapny Information
6.11.2 Tiantan Biological Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments
6.12 EuBiologics
6.12.1 EuBiologics Comapny Information
6.12.2 EuBiologics Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Comapny Information
6.13.2 Panacea Biotec Ltd Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments
6.14 Bio-Med
6.14.1 Bio-Med Comapny Information
6.14.2 Bio-Med Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
6.15.2 Halfkin Bio-Pharmaceuticals Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Oral Vaccines Sales by Country
7.1.1 North America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Oral Vaccines Sales by Country (2019-2024)
7.1.3 North America Oral Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Oral Vaccines Market Size by Country
7.2.1 North America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Oral Vaccines Market Size by Country (2019-2024)
7.2.3 North America Oral Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Oral Vaccines Sales by Country
8.1.1 Europe Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Oral Vaccines Sales by Country (2019-2024)
8.1.3 Europe Oral Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Oral Vaccines Market Size by Country
8.2.1 Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Oral Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Oral Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Oral Vaccines Sales by Country
9.1.1 Asia-Pacific Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Oral Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Oral Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Oral Vaccines Market Size by Country
9.2.1 Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Oral Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Oral Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Oral Vaccines Sales by Country
10.1.1 Latin America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Oral Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Oral Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Oral Vaccines Market Size by Country
10.2.1 Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Oral Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Oral Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Oral Vaccines Sales by Country
11.1.1 Middle East and Africa Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Oral Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Oral Vaccines Market Size by Country
11.2.1 Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Oral Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Oral Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Oral Vaccines Value Chain Analysis
12.1.1 Oral Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oral Vaccines Production Mode & Process
12.2 Oral Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oral Vaccines Distributors
12.2.3 Oral Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Oral Vaccines Market Size Estimates and Forecasts (2019-2030)
1.2.2 Global Oral Vaccines Sales Estimates and Forecasts (2019-2030)
1.3 Oral Vaccines Market by Type
1.3.1 Rotavirus Vaccine
1.3.2 Cholera Vaccine
1.3.3 Oral Polio Vaccine
1.4 Global Oral Vaccines Market Size by Type
1.4.1 Global Oral Vaccines Market Size Overview by Type (2019-2030)
1.4.2 Global Oral Vaccines Historic Market Size Review by Type (2019-2024)
1.4.3 Global Oral Vaccines Forecasted Market Size by Type (2025-2030)
1.5 Key Regions Market Size by Type
1.5.1 North America Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.2 Europe Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.3 Asia-Pacific Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.4 Latin America Oral Vaccines Sales Breakdown by Type (2019-2024)
1.5.5 Middle East and Africa Oral Vaccines Sales Breakdown by Type (2019-2024)
2 GLOBAL MARKET DYNAMICS
2.1 Oral Vaccines Industry Trends
2.2 Oral Vaccines Industry Drivers
2.3 Oral Vaccines Industry Opportunities and Challenges
2.4 Oral Vaccines Industry Restraints
3 MARKET COMPETITIVE LANDSCAPE BY COMPANY
3.1 Global Top Players by Oral Vaccines Revenue (2019-2024)
3.2 Global Top Players by Oral Vaccines Sales (2019-2024)
3.3 Global Top Players by Oral Vaccines Price (2019-2024)
3.4 Global Oral Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
3.5 Global Oral Vaccines Key Company Manufacturing Sites & Headquarters
3.6 Global Oral Vaccines Company, Product Type & Application
3.7 Global Oral Vaccines Company Commercialization Time
3.8 Market Competitive Analysis
3.8.1 Global Oral Vaccines Market CR5 and HHI
3.8.2 Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
3.8.3 2023 Oral Vaccines Tier 1, Tier 2, and Tier
4 ORAL VACCINES REGIONAL STATUS AND OUTLOOK
4.1 Global Oral Vaccines Market Size and CAGR by Region: 2019 VS 2023 VS 2030
4.2 Global Oral Vaccines Historic Market Size by Region
4.2.1 Global Oral Vaccines Sales in Volume by Region (2019-2024)
4.2.2 Global Oral Vaccines Sales in Value by Region (2019-2024)
4.2.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2019-2024)
4.3 Global Oral Vaccines Forecasted Market Size by Region
4.3.1 Global Oral Vaccines Sales in Volume by Region (2025-2030)
4.3.2 Global Oral Vaccines Sales in Value by Region (2025-2030)
4.3.3 Global Oral Vaccines Sales (Volume & Value), Price and Gross Margin (2025-2030)
5 ORAL VACCINES BY APPLICATION
5.1 Oral Vaccines Market by Application
5.1.1 Public
5.1.2 Private
5.2 Global Oral Vaccines Market Size by Application
5.2.1 Global Oral Vaccines Market Size Overview by Application (2019-2030)
5.2.2 Global Oral Vaccines Historic Market Size Review by Application (2019-2024)
5.2.3 Global Oral Vaccines Forecasted Market Size by Application (2025-2030)
5.3 Key Regions Market Size by Application
5.3.1 North America Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.2 Europe Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.3 Asia-Pacific Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.4 Latin America Oral Vaccines Sales Breakdown by Application (2019-2024)
5.3.5 Middle East and Africa Oral Vaccines Sales Breakdown by Application (2019-2024)
6 COMPANY PROFILES
6.1 Merck
6.1.1 Merck Comapny Information
6.1.2 Merck Business Overview
6.1.3 Merck Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Oral Vaccines Product Portfolio
6.1.5 Merck Recent Developments
6.2 GSK
6.2.1 GSK Comapny Information
6.2.2 GSK Business Overview
6.2.3 GSK Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK Oral Vaccines Product Portfolio
6.2.5 GSK Recent Developments
6.3 Sanofi
6.3.1 Sanofi Comapny Information
6.3.2 Sanofi Business Overview
6.3.3 Sanofi Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sanofi Oral Vaccines Product Portfolio
6.3.5 Sanofi Recent Developments
6.4 Lanzhou Institute
6.4.1 Lanzhou Institute Comapny Information
6.4.2 Lanzhou Institute Business Overview
6.4.3 Lanzhou Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Lanzhou Institute Oral Vaccines Product Portfolio
6.4.5 Lanzhou Institute Recent Developments
6.5 Serum Institute
6.5.1 Serum Institute Comapny Information
6.5.2 Serum Institute Business Overview
6.5.3 Serum Institute Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute Oral Vaccines Product Portfolio
6.5.5 Serum Institute Recent Developments
6.6 Valneva
6.6.1 Valneva Comapny Information
6.6.2 Valneva Business Overview
6.6.3 Valneva Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Valneva Oral Vaccines Product Portfolio
6.6.5 Valneva Recent Developments
6.7 Shanghai United Cell
6.7.1 Shanghai United Cell Comapny Information
6.7.2 Shanghai United Cell Business Overview
6.7.3 Shanghai United Cell Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Shanghai United Cell Oral Vaccines Product Portfolio
6.7.5 Shanghai United Cell Recent Developments
6.8 Bibcol
6.8.1 Bibcol Comapny Information
6.8.2 Bibcol Business Overview
6.8.3 Bibcol Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Bibcol Oral Vaccines Product Portfolio
6.8.5 Bibcol Recent Developments
6.9 PaxVax
6.9.1 PaxVax Comapny Information
6.9.2 PaxVax Business Overview
6.9.3 PaxVax Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.9.4 PaxVax Oral Vaccines Product Portfolio
6.9.5 PaxVax Recent Developments
6.10 Vabiotech
6.10.1 Vabiotech Comapny Information
6.10.2 Vabiotech Business Overview
6.10.3 Vabiotech Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vabiotech Oral Vaccines Product Portfolio
6.10.5 Vabiotech Recent Developments
6.11 Tiantan Biological
6.11.1 Tiantan Biological Comapny Information
6.11.2 Tiantan Biological Business Overview
6.11.3 Tiantan Biological Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Tiantan Biological Oral Vaccines Product Portfolio
6.11.5 Tiantan Biological Recent Developments
6.12 EuBiologics
6.12.1 EuBiologics Comapny Information
6.12.2 EuBiologics Business Overview
6.12.3 EuBiologics Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.12.4 EuBiologics Oral Vaccines Product Portfolio
6.12.5 EuBiologics Recent Developments
6.13 Panacea Biotec Ltd
6.13.1 Panacea Biotec Ltd Comapny Information
6.13.2 Panacea Biotec Ltd Business Overview
6.13.3 Panacea Biotec Ltd Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Panacea Biotec Ltd Oral Vaccines Product Portfolio
6.13.5 Panacea Biotec Ltd Recent Developments
6.14 Bio-Med
6.14.1 Bio-Med Comapny Information
6.14.2 Bio-Med Business Overview
6.14.3 Bio-Med Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Bio-Med Oral Vaccines Product Portfolio
6.14.5 Bio-Med Recent Developments
6.15 Halfkin Bio-Pharmaceuticals
6.15.1 Halfkin Bio-Pharmaceuticals Comapny Information
6.15.2 Halfkin Bio-Pharmaceuticals Business Overview
6.15.3 Halfkin Bio-Pharmaceuticals Oral Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments
7 NORTH AMERICA BY COUNTRY
7.1 North America Oral Vaccines Sales by Country
7.1.1 North America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.1.2 North America Oral Vaccines Sales by Country (2019-2024)
7.1.3 North America Oral Vaccines Sales Forecast by Country (2025-2030)
7.2 North America Oral Vaccines Market Size by Country
7.2.1 North America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2.2 North America Oral Vaccines Market Size by Country (2019-2024)
7.2.3 North America Oral Vaccines Market Size Forecast by Country (2025-2030)
8 EUROPE BY COUNTRY
8.1 Europe Oral Vaccines Sales by Country
8.1.1 Europe Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.1.2 Europe Oral Vaccines Sales by Country (2019-2024)
8.1.3 Europe Oral Vaccines Sales Forecast by Country (2025-2030)
8.2 Europe Oral Vaccines Market Size by Country
8.2.1 Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2.2 Europe Oral Vaccines Market Size by Country (2019-2024)
8.2.3 Europe Oral Vaccines Market Size Forecast by Country (2025-2030)
9 ASIA-PACIFIC BY COUNTRY
9.1 Asia-Pacific Oral Vaccines Sales by Country
9.1.1 Asia-Pacific Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.1.2 Asia-Pacific Oral Vaccines Sales by Country (2019-2024)
9.1.3 Asia-Pacific Oral Vaccines Sales Forecast by Country (2025-2030)
9.2 Asia-Pacific Oral Vaccines Market Size by Country
9.2.1 Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2.2 Asia-Pacific Oral Vaccines Market Size by Country (2019-2024)
9.2.3 Asia-Pacific Oral Vaccines Market Size Forecast by Country (2025-2030)
10 LATIN AMERICA BY COUNTRY
10.1 Latin America Oral Vaccines Sales by Country
10.1.1 Latin America Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.1.2 Latin America Oral Vaccines Sales by Country (2019-2024)
10.1.3 Latin America Oral Vaccines Sales Forecast by Country (2025-2030)
10.2 Latin America Oral Vaccines Market Size by Country
10.2.1 Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2.2 Latin America Oral Vaccines Market Size by Country (2019-2024)
10.2.3 Latin America Oral Vaccines Market Size Forecast by Country (2025-2030)
11 MIDDLE EAST AND AFRICA BY COUNTRY
11.1 Middle East and Africa Oral Vaccines Sales by Country
11.1.1 Middle East and Africa Oral Vaccines Sales Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.1.2 Middle East and Africa Oral Vaccines Sales by Country (2019-2024)
11.1.3 Middle East and Africa Oral Vaccines Sales Forecast by Country (2025-2030)
11.2 Middle East and Africa Oral Vaccines Market Size by Country
11.2.1 Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2.2 Middle East and Africa Oral Vaccines Market Size by Country (2019-2024)
11.2.3 Middle East and Africa Oral Vaccines Market Size Forecast by Country (2025-2030)
12 VALUE CHAIN AND SALES CHANNELS ANALYSIS
12.1 Oral Vaccines Value Chain Analysis
12.1.1 Oral Vaccines Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Oral Vaccines Production Mode & Process
12.2 Oral Vaccines Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Oral Vaccines Distributors
12.2.3 Oral Vaccines Customers
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Major Company of Rotavirus Vaccine
Table 2. Major Company of Cholera Vaccine
Table 3. Major Company of Oral Polio Vaccine
Table 4. Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 6. Global Oral Vaccines Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Oral Vaccines Sales Market Share in Value by Type (2019-2024)
Table 9. Global Oral Vaccines Price by Type (2019-2024) & (USD/K Doses)
Table 10. Global Oral Vaccines Sales by Type (2025-2030) & (M Doses)
Table 11. Global Oral Vaccines Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Oral Vaccines Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Oral Vaccines Sales Market Share in Value by Type (2025-2030)
Table 14. Global Oral Vaccines Price by Type (2025-2030) & (USD/K Doses)
Table 15. North America Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 16. North America Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 18. Europe Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 20. Asia-Pacific Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 22. Latin America Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 24. Middle East and Africa Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 25. Oral Vaccines Industry Trends
Table 26. Oral Vaccines Industry Drivers
Table 27. Oral Vaccines Industry Opportunities and Challenges
Table 28. Oral Vaccines Industry Restraints
Table 29. Global Oral Vaccines Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Oral Vaccines Revenue Market Share by Company (2019-2024)
Table 31. Global Oral Vaccines Sales by Company (2019-2024) & (M Doses)
Table 32. Global Oral Vaccines Sales Share by Company (2019-2024)
Table 33. Global Oral Vaccines Market Price by Company (2019-2024) & (USD/K Doses)
Table 34. Global Oral Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Oral Vaccines Key Company Manufacturing Sites & Headquarters
Table 36. Global Oral Vaccines Company, Product Type & Application
Table 37. Global Oral Vaccines Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Oral Vaccines Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 42. Global Oral Vaccines Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Oral Vaccines Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Oral Vaccines Sales Market Share in Value by Region (2019-2024)
Table 45. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 46. Global Oral Vaccines Sales by Region (2025-2030) & (M Doses)
Table 47. Global Oral Vaccines Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Oral Vaccines Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Oral Vaccines Sales Market Share in Value by Region (2025-2030)
Table 50. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 51. Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 53. Global Oral Vaccines Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Oral Vaccines Sales Market Share in Value by Application (2019-2024)
Table 56. Global Oral Vaccines Price by Application (2019-2024) & (USD/K Doses)
Table 57. Global Oral Vaccines Sales by Application (2025-2030) & (M Doses)
Table 58. Global Oral Vaccines Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Oral Vaccines Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Oral Vaccines Sales Market Share in Value by Application (2025-2030)
Table 61. Global Oral Vaccines Price by Application (2025-2030) & (USD/K Doses)
Table 62. North America Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 63. North America Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 67. Asia-Pacific Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 69. Latin America Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 71. Middle East and Africa Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 72. Merck Company Information
Table 73. Merck Business Overview
Table 74. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 75. Merck Oral Vaccines Product Portfolio
Table 76. Merck Recent Development
Table 77. GSK Company Information
Table 78. GSK Business Overview
Table 79. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 80. GSK Oral Vaccines Product Portfolio
Table 81. GSK Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Business Overview
Table 84. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 85. Sanofi Oral Vaccines Product Portfolio
Table 86. Sanofi Recent Development
Table 87. Lanzhou Institute Company Information
Table 88. Lanzhou Institute Business Overview
Table 89. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 90. Lanzhou Institute Oral Vaccines Product Portfolio
Table 91. Lanzhou Institute Recent Development
Table 92. Serum Institute Company Information
Table 93. Serum Institute Business Overview
Table 94. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 95. Serum Institute Oral Vaccines Product Portfolio
Table 96. Serum Institute Recent Development
Table 97. Valneva Company Information
Table 98. Valneva Business Overview
Table 99. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 100. Valneva Oral Vaccines Product Portfolio
Table 101. Valneva Recent Development
Table 102. Shanghai United Cell Company Information
Table 103. Shanghai United Cell Business Overview
Table 104. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 105. Shanghai United Cell Oral Vaccines Product Portfolio
Table 106. Shanghai United Cell Recent Development
Table 107. Bibcol Company Information
Table 108. Bibcol Business Overview
Table 109. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 110. Bibcol Oral Vaccines Product Portfolio
Table 111. Bibcol Recent Development
Table 112. PaxVax Company Information
Table 113. PaxVax Business Overview
Table 114. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 115. PaxVax Oral Vaccines Product Portfolio
Table 116. PaxVax Recent Development
Table 117. Vabiotech Company Information
Table 118. Vabiotech Business Overview
Table 119. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 120. Vabiotech Oral Vaccines Product Portfolio
Table 121. Vabiotech Recent Development
Table 122. Tiantan Biological Company Information
Table 123. Tiantan Biological Business Overview
Table 124. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 125. Tiantan Biological Oral Vaccines Product Portfolio
Table 126. Tiantan Biological Recent Development
Table 127. EuBiologics Company Information
Table 128. EuBiologics Business Overview
Table 129. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 130. EuBiologics Oral Vaccines Product Portfolio
Table 131. EuBiologics Recent Development
Table 132. Panacea Biotec Ltd Company Information
Table 133. Panacea Biotec Ltd Business Overview
Table 134. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 135. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 136. Panacea Biotec Ltd Recent Development
Table 137. Bio-Med Company Information
Table 138. Bio-Med Business Overview
Table 139. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 140. Bio-Med Oral Vaccines Product Portfolio
Table 141. Bio-Med Recent Development
Table 142. Halfkin Bio-Pharmaceuticals Company Information
Table 143. Halfkin Bio-Pharmaceuticals Business Overview
Table 144. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 145. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 146. Halfkin Bio-Pharmaceuticals Recent Development
Table 147. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 148. North America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 149. North America Oral Vaccines Sales Market Share by Country (2019-2024)
Table 150. North America Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 151. North America Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 152. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Oral Vaccines Market Share by Country (2019-2024)
Table 155. North America Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 157. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 158. Europe Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 159. Europe Oral Vaccines Sales Market Share by Country (2019-2024)
Table 160. Europe Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 161. Europe Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 162. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Europe Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 164. Europe Oral Vaccines Market Share by Country (2019-2024)
Table 165. Europe Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Europe Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 167. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 168. Asia-Pacific Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 169. Asia-Pacific Oral Vaccines Sales Market Share by Country (2019-2024)
Table 170. Asia-Pacific Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 171. Asia-Pacific Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 172. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Asia-Pacific Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 174. Asia-Pacific Oral Vaccines Market Share by Country (2019-2024)
Table 175. Asia-Pacific Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Asia-Pacific Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 177. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 178. Latin America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 179. Latin America Oral Vaccines Sales Market Share by Country (2019-2024)
Table 180. Latin America Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 181. Latin America Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 182. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Latin America Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 184. Latin America Oral Vaccines Market Share by Country (2019-2024)
Table 185. Latin America Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Latin America Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 187. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 188. Middle East and Africa Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 189. Middle East and Africa Oral Vaccines Sales Market Share by Country (2019-2024)
Table 190. Middle East and Africa Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 191. Middle East and Africa Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 192. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Middle East and Africa Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 194. Middle East and Africa Oral Vaccines Market Share by Country (2019-2024)
Table 195. Middle East and Africa Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Middle East and Africa Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Oral Vaccines Distributors List
Table 200. Oral Vaccines Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
Table 1. Major Company of Rotavirus Vaccine
Table 2. Major Company of Cholera Vaccine
Table 3. Major Company of Oral Polio Vaccine
Table 4. Global Oral Vaccines Sales by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 6. Global Oral Vaccines Sales Market Share in Volume by Type (2019-2024)
Table 7. Global Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 8. Global Oral Vaccines Sales Market Share in Value by Type (2019-2024)
Table 9. Global Oral Vaccines Price by Type (2019-2024) & (USD/K Doses)
Table 10. Global Oral Vaccines Sales by Type (2025-2030) & (M Doses)
Table 11. Global Oral Vaccines Sales Market Share in Volume by Type (2025-2030)
Table 12. Global Oral Vaccines Sales by Type (2025-2030) & (US$ Million)
Table 13. Global Oral Vaccines Sales Market Share in Value by Type (2025-2030)
Table 14. Global Oral Vaccines Price by Type (2025-2030) & (USD/K Doses)
Table 15. North America Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 16. North America Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 17. Europe Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 18. Europe Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 19. Asia-Pacific Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 20. Asia-Pacific Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 21. Latin America Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 22. Latin America Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 23. Middle East and Africa Oral Vaccines Sales by Type (2019-2024) & (M Doses)
Table 24. Middle East and Africa Oral Vaccines Sales by Type (2019-2024) & (US$ Million)
Table 25. Oral Vaccines Industry Trends
Table 26. Oral Vaccines Industry Drivers
Table 27. Oral Vaccines Industry Opportunities and Challenges
Table 28. Oral Vaccines Industry Restraints
Table 29. Global Oral Vaccines Sales Revenue by Company (US$ Million) & (2019-2024)
Table 30. Global Oral Vaccines Revenue Market Share by Company (2019-2024)
Table 31. Global Oral Vaccines Sales by Company (2019-2024) & (M Doses)
Table 32. Global Oral Vaccines Sales Share by Company (2019-2024)
Table 33. Global Oral Vaccines Market Price by Company (2019-2024) & (USD/K Doses)
Table 34. Global Oral Vaccines Industry Company Ranking, 2022 VS 2023 VS 2024
Table 35. Global Oral Vaccines Key Company Manufacturing Sites & Headquarters
Table 36. Global Oral Vaccines Company, Product Type & Application
Table 37. Global Oral Vaccines Company Commercialization Time
Table 38. Global Company Market Concentration Ratio (CR5 and HHI)
Table 39. Global Oral Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 40. Global Oral Vaccines Market Size Comparison by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Global Oral Vaccines Sales by Region (2019-2024) & (M Doses)
Table 42. Global Oral Vaccines Sales Market Share in Volume by Region (2019-2024)
Table 43. Global Oral Vaccines Sales by Region (2019-2024) & (US$ Million)
Table 44. Global Oral Vaccines Sales Market Share in Value by Region (2019-2024)
Table 45. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 46. Global Oral Vaccines Sales by Region (2025-2030) & (M Doses)
Table 47. Global Oral Vaccines Sales Market Share in Volume by Region (2025-2030)
Table 48. Global Oral Vaccines Sales by Region (2025-2030) & (US$ Million)
Table 49. Global Oral Vaccines Sales Market Share in Value by Region (2025-2030)
Table 50. Global Oral Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2025-2030)
Table 51. Global Oral Vaccines Sales by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 52. Global Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 53. Global Oral Vaccines Sales Market Share in Volume by Application (2019-2024)
Table 54. Global Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 55. Global Oral Vaccines Sales Market Share in Value by Application (2019-2024)
Table 56. Global Oral Vaccines Price by Application (2019-2024) & (USD/K Doses)
Table 57. Global Oral Vaccines Sales by Application (2025-2030) & (M Doses)
Table 58. Global Oral Vaccines Sales Market Share in Volume by Application (2025-2030)
Table 59. Global Oral Vaccines Sales by Application (2025-2030) & (US$ Million)
Table 60. Global Oral Vaccines Sales Market Share in Value by Application (2025-2030)
Table 61. Global Oral Vaccines Price by Application (2025-2030) & (USD/K Doses)
Table 62. North America Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 63. North America Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 64. Europe Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 65. Europe Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 66. Asia-Pacific Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 67. Asia-Pacific Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 68. Latin America Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 69. Latin America Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 70. Middle East and Africa Oral Vaccines Sales by Application (2019-2024) & (M Doses)
Table 71. Middle East and Africa Oral Vaccines Sales by Application (2019-2024) & (US$ Million)
Table 72. Merck Company Information
Table 73. Merck Business Overview
Table 74. Merck Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 75. Merck Oral Vaccines Product Portfolio
Table 76. Merck Recent Development
Table 77. GSK Company Information
Table 78. GSK Business Overview
Table 79. GSK Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 80. GSK Oral Vaccines Product Portfolio
Table 81. GSK Recent Development
Table 82. Sanofi Company Information
Table 83. Sanofi Business Overview
Table 84. Sanofi Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 85. Sanofi Oral Vaccines Product Portfolio
Table 86. Sanofi Recent Development
Table 87. Lanzhou Institute Company Information
Table 88. Lanzhou Institute Business Overview
Table 89. Lanzhou Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 90. Lanzhou Institute Oral Vaccines Product Portfolio
Table 91. Lanzhou Institute Recent Development
Table 92. Serum Institute Company Information
Table 93. Serum Institute Business Overview
Table 94. Serum Institute Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 95. Serum Institute Oral Vaccines Product Portfolio
Table 96. Serum Institute Recent Development
Table 97. Valneva Company Information
Table 98. Valneva Business Overview
Table 99. Valneva Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 100. Valneva Oral Vaccines Product Portfolio
Table 101. Valneva Recent Development
Table 102. Shanghai United Cell Company Information
Table 103. Shanghai United Cell Business Overview
Table 104. Shanghai United Cell Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 105. Shanghai United Cell Oral Vaccines Product Portfolio
Table 106. Shanghai United Cell Recent Development
Table 107. Bibcol Company Information
Table 108. Bibcol Business Overview
Table 109. Bibcol Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 110. Bibcol Oral Vaccines Product Portfolio
Table 111. Bibcol Recent Development
Table 112. PaxVax Company Information
Table 113. PaxVax Business Overview
Table 114. PaxVax Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 115. PaxVax Oral Vaccines Product Portfolio
Table 116. PaxVax Recent Development
Table 117. Vabiotech Company Information
Table 118. Vabiotech Business Overview
Table 119. Vabiotech Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 120. Vabiotech Oral Vaccines Product Portfolio
Table 121. Vabiotech Recent Development
Table 122. Tiantan Biological Company Information
Table 123. Tiantan Biological Business Overview
Table 124. Tiantan Biological Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 125. Tiantan Biological Oral Vaccines Product Portfolio
Table 126. Tiantan Biological Recent Development
Table 127. EuBiologics Company Information
Table 128. EuBiologics Business Overview
Table 129. EuBiologics Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 130. EuBiologics Oral Vaccines Product Portfolio
Table 131. EuBiologics Recent Development
Table 132. Panacea Biotec Ltd Company Information
Table 133. Panacea Biotec Ltd Business Overview
Table 134. Panacea Biotec Ltd Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 135. Panacea Biotec Ltd Oral Vaccines Product Portfolio
Table 136. Panacea Biotec Ltd Recent Development
Table 137. Bio-Med Company Information
Table 138. Bio-Med Business Overview
Table 139. Bio-Med Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 140. Bio-Med Oral Vaccines Product Portfolio
Table 141. Bio-Med Recent Development
Table 142. Halfkin Bio-Pharmaceuticals Company Information
Table 143. Halfkin Bio-Pharmaceuticals Business Overview
Table 144. Halfkin Bio-Pharmaceuticals Oral Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/K Doses) and Gross Margin (2019-2024)
Table 145. Halfkin Bio-Pharmaceuticals Oral Vaccines Product Portfolio
Table 146. Halfkin Bio-Pharmaceuticals Recent Development
Table 147. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 148. North America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 149. North America Oral Vaccines Sales Market Share by Country (2019-2024)
Table 150. North America Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 151. North America Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 152. North America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 153. North America Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 154. North America Oral Vaccines Market Share by Country (2019-2024)
Table 155. North America Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 156. North America Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 157. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 158. Europe Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 159. Europe Oral Vaccines Sales Market Share by Country (2019-2024)
Table 160. Europe Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 161. Europe Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 162. Europe Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 163. Europe Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 164. Europe Oral Vaccines Market Share by Country (2019-2024)
Table 165. Europe Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 166. Europe Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 167. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 168. Asia-Pacific Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 169. Asia-Pacific Oral Vaccines Sales Market Share by Country (2019-2024)
Table 170. Asia-Pacific Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 171. Asia-Pacific Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 172. Asia-Pacific Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 173. Asia-Pacific Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 174. Asia-Pacific Oral Vaccines Market Share by Country (2019-2024)
Table 175. Asia-Pacific Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 176. Asia-Pacific Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 177. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 178. Latin America Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 179. Latin America Oral Vaccines Sales Market Share by Country (2019-2024)
Table 180. Latin America Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 181. Latin America Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 182. Latin America Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 183. Latin America Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 184. Latin America Oral Vaccines Market Share by Country (2019-2024)
Table 185. Latin America Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 186. Latin America Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 187. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2019 VS 2023 VS 2030
Table 188. Middle East and Africa Oral Vaccines Sales by Country (2019-2024) & (M Doses)
Table 189. Middle East and Africa Oral Vaccines Sales Market Share by Country (2019-2024)
Table 190. Middle East and Africa Oral Vaccines Sales Forecast by Country (2025-2030) & (M Doses)
Table 191. Middle East and Africa Oral Vaccines Sales Market Share Forecast by Country (2025-2030)
Table 192. Middle East and Africa Oral Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
Table 193. Middle East and Africa Oral Vaccines Market Size by Country (2019-2024) & (US$ Million)
Table 194. Middle East and Africa Oral Vaccines Market Share by Country (2019-2024)
Table 195. Middle East and Africa Oral Vaccines Market Size Forecast by Country (2025-2030) & (US$ Million)
Table 196. Middle East and Africa Oral Vaccines Market Share Forecast by Country (2025-2030)
Table 197. Key Raw Materials
Table 198. Raw Materials Key Suppliers
Table 199. Oral Vaccines Distributors List
Table 200. Oral Vaccines Customers List
Table 201. Research Programs/Design for This Report
Table 202. Authors List of This Report
Table 203. Secondary Sources
Table 204. Primary Sources
LIST OF FIGURES
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Rotavirus Vaccine
Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Cholera Vaccine
Figure 8. Global Cholera Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Product Picture of Oral Polio Vaccine
Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 11. Global Oral Vaccines Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Oral Vaccines Market Share by Type 2023 VS 2030
Figure 13. North America Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 14. North America Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 15. Europe Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 16. Europe Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 19. Latin America Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Public
Figure 26. Global Public Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Product Picture of Private
Figure 28. Global Private Sales YoY Growth (2019-2030) & (M Doses)
Figure 29. Global Oral Vaccines Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Oral Vaccines Market Share by Application 2023 VS 2030
Figure 31. North America Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 32. North America Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 33. Europe Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 34. Europe Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 37. Latin America Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 41. North America Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 42. North America Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 46. Europe Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 50. Asia-Pacific Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Oral Vaccines Sales by Country: 2019 VS 2023
Figure 1. Oral Vaccines Product Picture
Figure 2. Global Oral Vaccines Market Size (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Oral Vaccines Market Size (2019-2030) & (US$ Million)
Figure 4. Global Oral Vaccines Sales (2019-2030) & (M Doses)
Figure 5. Product Picture of Rotavirus Vaccine
Figure 6. Global Rotavirus Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 7. Product Picture of Cholera Vaccine
Figure 8. Global Cholera Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 9. Product Picture of Oral Polio Vaccine
Figure 10. Global Oral Polio Vaccine Sales YoY Growth (2019-2030) & (M Doses)
Figure 11. Global Oral Vaccines Market Size Overview by Type (2019-2030) & (US$ Million)
Figure 12. Global Oral Vaccines Market Share by Type 2023 VS 2030
Figure 13. North America Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 14. North America Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 15. Europe Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 16. Europe Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 17. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 18. Asia-Pacific Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 19. Latin America Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 20. Latin America Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 21. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Type in 2023
Figure 22. Middle East and Africa Oral Vaccines Sales Market Share in Value by Type in 2023
Figure 23. Global Top 5 and 10 Oral Vaccines Players Market Share by Revenue in 2023
Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 25. Product Picture of Public
Figure 26. Global Public Sales YoY Growth (2019-2030) & (M Doses)
Figure 27. Product Picture of Private
Figure 28. Global Private Sales YoY Growth (2019-2030) & (M Doses)
Figure 29. Global Oral Vaccines Market Size Overview by Application (2019-2030) & (US$ Million)
Figure 30. Global Oral Vaccines Market Share by Application 2023 VS 2030
Figure 31. North America Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 32. North America Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 33. Europe Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 34. Europe Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 35. Asia-Pacific Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 36. Asia-Pacific Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 37. Latin America Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 38. Latin America Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 39. Middle East and Africa Oral Vaccines Sales Market Share in Volume by Application in 2023
Figure 40. Middle East and Africa Oral Vaccines Sales Market Share in Value by Application in 2023
Figure 41. North America Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 42. North America Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 43. North America Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 44. North America Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 45. Europe Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 46. Europe Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 47. Europe Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 48. Europe Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 49. Asia-Pacific Oral Vaccines Sales by Country: 2019 VS 2023 VS 2030 (M Doses)
Figure 50. Asia-Pacific Oral Vaccines Sales Share by Country: 2019 VS 2023 VS 2030
Figure 51. Asia-Pacific Oral Vaccines Market Size by Country: 2019 VS 2023 VS 2030 (US$ Million)
Figure 52. Asia-Pacific Oral Vaccines Market Share by Country: 2019 VS 2023 VS 2030
Figure 53. Latin America Oral Vaccines Sales by Country: 2019 VS 2023
